In acute myeloid leukemia (AML), NAT10 knockout blocks the translational efficiency of target genes such as SLC1 A4 and HOXA9/MENIN, disrupts serine metabolic reprogramming, impairs leukemia stem cell self-renewal, and enhances chemotherapeutic sensitivity [176]. The gene discussed is NAT10; the disease is acute myeloid leukemia.